Bristol-Myers Squibb Positions Itself for Growth in T-Cell Therapy Market Amid Challenges and Strategic Innovations

Bristol-Myers Squibb is navigating the dynamic T-cell therapy market with strategic innovations and a focus on cost management, despite facing challenges with its immunotherapy Opdualag. As the company positions itself for growth, can its robust pipeline and recent acquisitions sustain its competitive edge in oncology?